Sector
Healthcare stocks
414 Healthcare companies have a page on Investingly, worth $8.90T together. The largest is Eli Lilly and (LLY) at $1.08T.
The median company trades at 28.0 times earnings, keeps 5.8% of revenue as operating profit and grew revenue 9.1% over the last year.
Nuvation Bio grew revenue fastest (+556%); Arbutus Biopharma has the widest operating margin (82%); 65 of them pay a dividend (median yield 1.3%).
Companies414
Total market cap$8.90T
Median P/E28.0x
Median operating margin5.8%
Median revenue growth+9.1%
Median dividend yield1.3%
Healthcare companies, largest first (top 200)
| # | Company | Market cap | P/E | P/FCF | Revenue growth | Operating margin | ROE | Dividend yield |
|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly and CompanyLLY | $1.08T | 43.0x | 120.2x | +47.7% | — | 78.8% | 0.53% |
| 2 | Johnson & JohnsonJNJ | $632.9B | 30.5x | 32.1x | +6.6% | — | 24.8% | — |
| 3 | AbbVie IncABBV | $492.9B | 78.1x | 27.7x | +10.2% | 26.2% | — | 2.4% |
| 4 | Merck & Company IncMRK | $362.1B | 41.3x | 29.3x | +5.1% | — | 7.6% | 2.3% |
| 5 | UnitedHealth Group IncorporatedUNH | $334.2B | 27.7x | 20.8x | +0.4% | 4.8% | 13.5% | 2.4% |
| 6 | Novartis AG ADRNVS | $275.6B | 20.1x | 15.6x | — | — | 33.3% | — |
| 7 | Thermo Fisher Scientific IncTMO | $245.5B | 36.3x | 39.0x | +10.5% | 17.6% | 13.2% | 0.27% |
| 8 | AstraZeneca PLCAZN | $238.8B | 24.3x | 20.3x | +8.6% | 23.4% | 22.9% | — |
| 9 | Amgen IncAMGN | $217.3B | 28.0x | 26.8x | +9.5% | 30.0% | 74.8% | 2.4% |
| 10 | Gilead Sciences IncGILD | $184.1B | 20.2x | 19.5x | +10.2% | -8.2% | -27.4% | 2.3% |
| 11 | Abbott LaboratoriesABT | $174.8B | 28.1x | 23.6x | +7.8% | 17.1% | 12.1% | 2.4% |
| 12 | Novo Nordisk A/SNVO | $161.1B | 8.53x | 5.56x | +6.4% | 41.3% | 52.8% | — |
| 13 | Pfizer IncPFE | $159.3B | 21.3x | 17.5x | +2.6% | — | 5.1% | — |
| 14 | Intuitive Surgical IncISRG | $153.4B | 52.8x | 61.6x | +18.5% | 31.3% | 17.3% | — |
| 15 | Danaher CorporationDHR | $151.8B | 41.6x | 28.9x | +5.5% | 20.4% | 7.6% | 0.64% |
| 16 | Vertex Pharmaceuticals IncVRTX | $123.0B | 28.8x | 38.5x | +12.4% | 38.0% | 21.8% | — |
| 17 | Bristol-Myers Squibb CompanyBMY | $122.0B | 16.7x | 9.50x | +5.7% | 24.2% | 41.6% | 4.1% |
| 18 | Medtronic PLCMDT | $117.1B | 25.5x | 22.6x | +13.7% | 18.1% | 10.4% | 3.2% |
| 19 | McKesson CorporationMCK | $116.6B | 25.3x | 20.4x | +7.7% | 1.6% | — | 0.35% |
| 20 | Stryker CorporationSYK | $111.8B | 28.7x | 26.1x | +9.4% | 21.4% | 15.6% | 1.2% |
| 21 | CVS Health CorpCVS | $109.7B | 37.7x | 14.0x | +7.3% | 2.0% | 6.1% | 3.1% |
| 22 | Sanofi ADRSNY | $98.6B | 17.9x | 9.72x | — | — | 10.9% | — |
| 23 | HCA Holdings IncHCA | $94.7B | 14.7x | 12.3x | +4.3% | 12.8% | — | 0.74% |
| 24 | GlaxoSmithKline PLC ADRGSK | $93.4B | 12.3x | 16.0x | +4.1% | 24.3% | 34.9% | — |
| 25 | Elevance Health IncELV | $88.9B | 17.3x | 28.0x | +1.4% | 2.7% | 11.1% | 1.7% |
| 26 | Moderna IncMRNA | $81.0B | — | — | +2.1% | -149.0% | -46.6% | — |
| 27 | Cigna CorpCI | $70.9B | 11.1x | 8.45x | +6.7% | 3.5% | 15.2% | 2.3% |
| 28 | Regeneron Pharmaceuticals IncREGN | $68.5B | 16.0x | 16.8x | +16.7% | 24.7% | 13.7% | 0.56% |
| 29 | Cencora Inc.COR | $63.5B | 25.0x | 19.8x | +5.1% | 0.91% | 86.0% | 0.75% |
| 30 | Boston Scientific CorpBSX | $63.1B | 17.8x | 17.2x | +7.5% | 19.8% | 14.7% | — |
| 31 | Takeda Pharmaceutical Co Ltd ADRTAK | $59.3B | 49.4x | 0.08x | +7.5% | 7.5% | 1.6% | — |
| 32 | Cardinal Health IncCAH | $58.3B | 32.9x | 31.5x | +14.2% | 1.0% | — | — |
| 33 | Natera IncNTRA | $57.6B | — | 527.9x | +37.7% | -10.7% | -10.6% | — |
| 34 | Humana IncHUM | $52.8B | 46.9x | 140.9x | +25.7% | 39.6% | 6.1% | 0.89% |
| 35 | Veeva Systems Inc Class AVEEV | $50.7B | 57.1x | 36.6x | +17.6% | 29.9% | 13.7% | — |
| 36 | argenx NV ADRARGX | $50.6B | 42.2x | 60.0x | +88.6% | 24.8% | 43.5% | — |
| 37 | Becton Dickinson and CompanyBDX | $50.4B | 32.0x | 18.9x | +5.4% | 10.7% | 3.9% | — |
| 38 | Edwards Lifesciences CorpEW | $49.5B | 46.5x | 37.1x | +13.6% | 22.2% | 9.5% | — |
| 39 | Agilent Technologies IncA | $47.8B | 37.2x | 41.4x | +8.1% | 22.2% | 19.6% | 0.60% |
| 40 | Teva Pharma Industries Ltd ADRTEVA | $45.0B | 28.8x | 39.2x | -0.8% | 9.3% | 9.1% | — |
| 41 | Waters CorporationWAT | $42.6B | 108.7x | 78.9x | +113.3% | 7.1% | 1.1% | — |
| 42 | IQVIA Holdings IncIQV | $42.3B | 31.5x | 20.7x | +8.4% | 13.2% | 22.3% | — |
| 43 | IDEXX Laboratories IncIDXX | $42.2B | 39.3x | 40.1x | +9.7% | 32.0% | 70.7% | — |
| 44 | Haleon plcHLN | $42.1B | 19.4x | 21.4x | -1.8% | 21.9% | 10.2% | — |
| 45 | Illumina IncILMN | $41.1B | 49.4x | 44.2x | +9.4% | 19.6% | 29.1% | — |
| 46 | Revolution Medicines IncRVMD | $39.6B | — | — | -100.0% | — | -67.8% | — |
| 47 | DexCom IncDXCM | $39.6B | 41.2x | 36.7x | +13.1% | 22.9% | 38.1% | — |
| 48 | ResMed IncRMD | $34.4B | 22.8x | 20.7x | +8.6% | 33.4% | 23.1% | 1.0% |
| 49 | BeiGene, Ltd.ONC | $34.1B | 74.1x | 36.2x | +29.6% | 15.1% | 12.7% | — |
| 50 | Mettler-Toledo International IncMTD | $33.4B | 38.9x | 39.4x | +4.5% | — | 7062.4% | — |
| 51 | Zoetis IncZTS | $33.3B | 13.0x | 14.6x | -0.2% | — | 83.1% | — |
| 52 | Royalty Pharma PlcRPRX | $32.3B | 29.5x | 13.0x | +16.5% | 59.6% | 8.3% | — |
| 53 | Alcon AGALC | $31.4B | 32.4x | 18.1x | +4.9% | 13.1% | 4.4% | — |
| 54 | GE HealthCare Technologies Inc.GEHC | $31.0B | 16.4x | 20.6x | +7.4% | 12.6% | 17.9% | 0.21% |
| 55 | Alnylam Pharmaceuticals IncALNY | $30.6B | 57.4x | 65.7x | +66.9% | — | 54.1% | — |
| 56 | Biogen IncBIIB | $30.4B | 22.2x | 14.8x | +1.9% | 16.3% | 7.4% | — |
| 57 | Medline Inc. Class A Common StockMDLN | $28.5B | — | 16.4x | +11.5% | 7.8% | 10.0% | — |
| 58 | Roivant Sciences LtdROIV | $27.2B | — | — | -33.5% | -7914.8% | -6.3% | — |
| 59 | West Pharmaceutical Services IncWST | $26.0B | 49.2x | 55.4x | +13.8% | 20.4% | 18.9% | 0.24% |
| 60 | Laboratory Corporation of America HoldingsLH | $25.9B | 28.0x | 21.5x | +5.8% | 10.4% | 11.7% | 0.92% |
| 61 | Quest Diagnostics IncorporatedDGX | $25.0B | 25.0x | 18.4x | +10.2% | 14.1% | 14.1% | 1.5% |
| 62 | BioNTech SEBNTX | $24.5B | — | — | +4.3% | -49.0% | -5.9% | — |
| 63 | Koninklijke Philips NV ADRPHG | $23.5B | 21.2x | 26.3x | -1.0% | 8.0% | 8.2% | — |
| 64 | United Therapeutics CorporationUTHR | $22.8B | 19.8x | 21.9x | -1.9% | 44.4% | 20.5% | — |
| 65 | Guardant Health IncGH | $22.1B | — | — | +44.3% | -39.8% | — | — |
| 66 | Genmab ASGMAB | $22.0B | 27.2x | 19.1x | +30.7% | 31.1% | 25.3% | — |
| 67 | Tenet Healthcare CorporationTHC | $21.9B | 13.2x | 8.65x | +6.8% | 20.8% | 48.1% | — |
| 68 | Incyte CorporationINCY | $21.8B | 15.4x | 16.1x | +20.9% | 30.1% | 25.5% | — |
| 69 | STERIS plcSTE | $21.4B | 27.5x | 22.0x | +7.3% | 18.9% | 11.2% | 1.2% |
| 70 | Insmed IncINSM | $19.6B | — | — | +296.1% | -73.9% | -115.5% | — |
| 71 | Viatris IncVTRS | $19.0B | — | 9.79x | +5.0% | -0.59% | — | — |
| 72 | Zimmer Biomet Holdings IncZBH | $17.9B | 24.0x | 12.2x | +4.8% | 14.2% | 6.4% | 1.1% |
| 73 | Medpace Holdings IncMEDP | $17.3B | 38.2x | 25.4x | +17.2% | 21.0% | 113.3% | — |
| 74 | Revvity Inc.RVTY | $17.3B | 74.5x | 34.0x | +1.3% | 12.3% | 3.3% | 0.18% |
| 75 | Solventum Corp.SOLV | $15.5B | 10.9x | — | +2.2% | 25.0% | 29.9% | — |
| 76 | Exelixis IncEXEL | $14.3B | 18.8x | 16.9x | +10.6% | 39.9% | 46.7% | — |
| 77 | Neurocrine Biosciences IncNBIX | $14.0B | 21.4x | 18.6x | +39.5% | 23.6% | 19.1% | — |
| 78 | Ascendis Pharma ASASND | $13.8B | 25.3x | 317.1x | +42.3% | -18.9% | — | — |
| 79 | Corcept Therapeutics IncorporatedCORT | $12.8B | 342.0x | 90.6x | +31.7% | 0.77% | 7.8% | — |
| 80 | Penumbra IncPEN | $12.7B | 74.5x | 72.7x | +14.9% | 12.4% | 10.5% | — |
| 81 | BrightSpring Health Services, Inc. Common StockBTSG | $12.7B | 84.8x | 32.1x | +23.1% | 3.1% | 17.9% | — |
| 82 | Halozyme Therapeutics IncHALO | $12.6B | 37.1x | 19.5x | +47.7% | 35.9% | 288.1% | — |
| 83 | ICON PLCICLR | $12.4B | 21.4x | 11.0x | +1.2% | 3.6% | 0.45% | — |
| 84 | BridgeBio Pharma IncBBIO | $12.3B | — | — | +120.4% | -69.8% | — | — |
| 85 | Summit Therapeutics PLCSMMT | $12.1B | — | — | — | — | -135.9% | — |
| 86 | Tempus AI, Inc. Class A Common StockTEM | $12.0B | — | — | +21.6% | -19.8% | -57.2% | — |
| 87 | Smith & Nephew SNATS IncSNN | $12.0B | 37.8x | 14.0x | +6.1% | 12.9% | 11.8% | — |
| 88 | Encompass Health CorpEHC | $11.9B | 20.6x | 27.1x | +9.6% | 18.0% | 23.9% | 0.64% |
| 89 | 10X Genomics IncTXG | $11.7B | — | 89.6x | -12.7% | -14.3% | -9.1% | — |
| 90 | Fresenius Medical Care CorporationFMS | $11.5B | 11.2x | 6.81x | -0.3% | 9.3% | 7.3% | — |
| 91 | DaVita HealthCare Partners IncDVA | $11.5B | 17.3x | 8.80x | +5.2% | 15.2% | — | — |
| 92 | Bio-Techne CorpTECH | $11.5B | 104.9x | 44.8x | +1.3% | 20.7% | 8.6% | 0.43% |
| 93 | Dr. Reddy’s Laboratories Ltd ADRRDY | $10.9B | 25.2x | 0.34x | +16.6% | 22.1% | 17.0% | — |
| 94 | Madrigal Pharmaceuticals IncMDGL | $10.7B | — | — | +71.2% | -25.1% | -62.1% | — |
| 95 | Globus MedicalGMED | $10.7B | 18.4x | 18.2x | +5.9% | 20.3% | 11.2% | — |
| 96 | The Cooper Companies, IncCOO | $10.6B | 27.1x | 24.5x | +0.6% | 12.8% | 6.8% | — |
| 97 | Immunitybio IncIBRX | $10.5B | — | — | +93.9% | -151.9% | — | — |
| 98 | Universal Health Services IncUHS | $10.4B | 7.21x | 12.3x | +8.3% | 11.4% | 20.3% | 0.48% |
| 99 | Oscar Health IncOSCR | $10.4B | — | 9.86x | -6.2% | 2128.9% | 26.8% | — |
| 100 | Elanco Animal HealthELAN | $10.4B | — | 36.6x | +10.2% | — | -3.0% | — |
| 101 | Biomarin Pharmaceutical IncBMRN | $10.2B | 38.1x | 14.1x | +19.9% | 4.4% | 1.1% | — |
| 102 | The Ensign Group IncENSG | $10.1B | 28.1x | 27.1x | +17.3% | 8.6% | 15.5% | 0.15% |
| 103 | Henry Schein IncHSIC | $10.0B | 26.6x | 17.5x | +6.7% | 5.0% | 12.8% | — |
| 104 | Bio-Rad Laboratories IncBIO | $10.0B | 61.9x | 26.6x | -0.1% | 2.0% | 3.1% | — |
| 105 | Repligen CorporationRGEN | $9.9B | 193.7x | 105.9x | +11.9% | 8.2% | 2.0% | — |
| 106 | Align Technology IncALGN | $9.9B | 23.4x | 20.2x | +4.3% | 13.2% | 9.8% | — |
| 107 | Glaukos CorpGKOS | $9.9B | — | — | +49.5% | -31.6% | -27.6% | — |
| 108 | Molina Healthcare IncMOH | $9.9B | 50.8x | — | -4.8% | 0.46% | -0.17% | — |
| 109 | Twist Bioscience CorpTWST | $9.8B | — | — | +23.2% | -33.6% | -30.7% | — |
| 110 | Qiagen NVQGEN | $9.8B | 23.4x | 21.6x | +5.7% | 22.3% | 11.2% | — |
| 111 | Insulet CorporationPODD | $9.7B | 32.8x | 25.8x | +23.5% | 16.9% | 26.4% | — |
| 112 | Krystal Biotech IncKRYS | $9.3B | 42.4x | 49.3x | +24.1% | 44.9% | 17.8% | — |
| 113 | Vaxcyte IncPCVX | $9.0B | — | — | — | — | -38.6% | — |
| 114 | Caris Life Sciences, Inc. Common StockCAI | $8.9B | — | 132.9x | +45.4% | 15.5% | 17.8% | — |
| 115 | Protagonist Therapeutics IncPTGX | $8.8B | — | 156.1x | +3749.2% | 20.7% | 9.8% | — |
| 116 | Kymera Therapeutics IncKYMR | $8.7B | — | — | +466.4% | -333.5% | -19.9% | — |
| 117 | Arrowhead Pharmaceuticals IncARWR | $8.7B | 39.3x | 55.5x | +171.0% | -33.8% | -68.7% | — |
| 118 | Axsome Therapeutics IncAXSM | $8.4B | — | — | +45.5% | -24.0% | -230.1% | — |
| 119 | Cytokinetics IncCYTK | $8.4B | — | — | -57.1% | -1046.1% | — | — |
| 120 | HealthEquity IncHQY | $8.3B | 40.1x | 18.2x | +7.6% | 25.8% | 11.9% | — |
| 121 | Hinge Health, Inc.HNGE | $8.1B | — | 47.2x | +53.0% | 13.0% | 31.7% | — |
| 122 | TG Therapeutics IncTGTX | $7.5B | 17.1x | — | +70.3% | 17.1% | 73.1% | — |
| 123 | AptarGroup IncATR | $7.5B | 20.1x | 24.9x | +6.3% | 12.1% | 13.8% | 1.6% |
| 124 | Spyre Therapeutics Inc.SYRE | $7.2B | — | — | — | — | -16.2% | — |
| 125 | Ionis Pharmaceuticals IncIONS | $7.1B | — | — | -40.7% | -68.0% | -128.5% | — |
| 126 | Hims Hers Health IncHIMS | $6.8B | 73.2x | 92.4x | +38.2% | -6.0% | -43.8% | — |
| 127 | Chemed CorpCHE | $6.8B | 27.9x | 20.9x | +8.8% | 13.5% | 33.1% | 0.49% |
| 128 | Praxis Precision Medicines IncPRAX | $6.7B | — | — | -100.0% | — | -25.3% | — |
| 129 | GRAIL, LLCGRAL | $6.6B | — | — | +25.7% | -338.4% | -15.4% | — |
| 130 | Abivax SA American Depositary SharesABVX | $6.6B | — | — | -89.8% | -5384.2% | -73.8% | — |
| 131 | Alkermes PlcALKS | $6.5B | 43.5x | 13.6x | +27.0% | 7.0% | 3.7% | — |
| 132 | Iovance Biotherapeutics IncIOVA | $6.4B | — | — | +65.7% | -92.7% | -39.3% | — |
| 133 | Lantheus Holdings IncLNTH | $6.3B | 23.0x | 17.7x | +2.7% | 19.4% | 21.0% | — |
| 134 | Amneal Pharmaceuticals, Inc. Class A Common StockAMRX | $6.1B | 51.8x | 22.7x | +9.9% | 14.6% | 476.5% | — |
| 135 | PACS Group, Inc.PACS | $6.1B | 24.9x | 20.4x | +9.1% | 7.4% | 24.2% | — |
| 136 | Bausch + Lomb CorpBLCO | $6.1B | — | — | +9.1% | 6.1% | -2.7% | — |
| 137 | Ligand Pharmaceuticals IncorporatedLGND | $6.1B | 39.5x | 124.2x | +33.7% | 32.6% | 20.4% | — |
| 138 | Rhythm Pharmaceuticals IncRYTM | $5.9B | — | — | +46.9% | -83.6% | -199.4% | — |
| 139 | Belite Bio Inc ADRBLTE | $5.8B | — | — | — | — | -10.1% | — |
| 140 | RadNet IncRDNT | $5.7B | — | 67.0x | +25.0% | 3.1% | -1.9% | — |
| 141 | Kiniksa Pharmaceuticals LtdKNSA | $5.6B | 80.5x | 221.8x | +55.5% | 12.4% | 12.1% | — |
| 142 | Haemonetics CorporationHAE | $5.6B | 60.5x | 21.6x | +5.6% | 11.9% | 11.5% | — |
| 143 | Immunovant IncIMVT | $5.6B | — | — | — | — | -73.2% | — |
| 144 | MiniMed Group, Inc. Common StockMMED | $5.5B | — | — | +16.6% | — | -8.5% | — |
| 145 | Kodiak Sciences IncKOD | $5.4B | — | — | — | — | -396.1% | — |
| 146 | Grifols SA ADRGRFS | $5.3B | 11.1x | 7.11x | +9.4% | 16.5% | 2.7% | — |
| 147 | Stevanato Group SpASTVN | $5.3B | 33.1x | 248.8x | +7.5% | 16.8% | 9.4% | — |
| 148 | Erasca IncERAS | $5.3B | — | — | — | — | -79.4% | — |
| 149 | Merit Medical Systems IncMMSI | $5.3B | 38.3x | 24.6x | +9.5% | 12.8% | 8.7% | — |
| 150 | Option Care Health IncOPCH | $5.1B | 25.6x | 19.9x | +1.3% | 5.8% | 15.3% | — |
| 151 | PTC Therapeutics IncPTCT | $5.1B | 6.69x | 7.31x | +101.5% | 12.4% | — | — |
| 152 | CG Oncology, Inc. Common stockCGON | $5.1B | — | — | — | -4056.2% | -21.8% | — |
| 153 | Waystar Holding Corp. Common StockWAY | $5.1B | 39.5x | 17.9x | +18.1% | 22.9% | 3.4% | — |
| 154 | Sotera Health CoSHC | $5.1B | 43.3x | 34.0x | +9.2% | — | 24.6% | — |
| 155 | Cogent Biosciences IncCOGT | $5.0B | — | — | -100.0% | — | -70.8% | — |
| 156 | Crispr Therapeutics AGCRSP | $4.8B | — | — | +1041.4% | -3990.0% | -25.8% | — |
| 157 | Scholar Rock Holding CorpSRRK | $4.8B | — | — | — | — | -161.0% | — |
| 158 | Concentra Group Holdings Parent, Inc.CON | $4.8B | 26.8x | 24.2x | +10.0% | 16.4% | 41.6% | 0.69% |
| 159 | Mirum Pharmaceuticals IncMIRM | $4.7B | — | 84.9x | +37.9% | -134.9% | — | — |
| 160 | Doximity IncDOCS | $4.7B | 25.2x | 14.3x | +7.3% | 29.6% | 18.2% | — |
| 161 | Oruka Therapeutics, Inc.ORKA | $4.6B | — | — | — | — | -11.9% | — |
| 162 | Travere Therapeutics IncTVTX | $4.6B | — | 121.7x | +48.2% | -6.8% | -177.2% | — |
| 163 | Lifestance Health Group IncLFST | $4.6B | 199.3x | 41.5x | +26.1% | 5.0% | 3.4% | — |
| 164 | Dianthus Therapeutics Inc.DNTH | $4.5B | — | — | -78.6% | — | -16.4% | — |
| 165 | Integer Holdings CorpITGR | $4.3B | 31.8x | 41.4x | -2.6% | 9.7% | 7.5% | — |
| 166 | ICU Medical IncICUI | $4.3B | 92.7x | 47.0x | +0.5% | 3.3% | 1.4% | — |
| 167 | BillionToOne, Inc. Class A Common StockBLLN | $4.3B | 172.7x | 273.0x | +64.4% | 10.9% | 7.0% | — |
| 168 | Veracyte IncVCYT | $4.3B | 49.5x | 33.7x | +15.5% | 18.8% | 8.2% | — |
| 169 | LivaNova PLCLIVN | $4.2B | 39.2x | 24.4x | +10.8% | 12.7% | 14.2% | — |
| 170 | Adaptive Biotechnologies CorpADPT | $4.1B | — | — | +21.5% | -12.2% | -44.7% | — |
| 171 | Indivior PLC Ordinary SharesINDV | $4.1B | 17.9x | — | +13.6% | 31.6% | — | — |
| 172 | Edgewise Therapeutics IncEWTX | $3.9B | — | — | — | — | -44.0% | — |
| 173 | Definium Therapeutics, Inc.DFTX | $3.8B | — | — | — | — | -38.5% | — |
| 174 | Pulse Biosciences IncPLSE | $3.7B | — | — | — | -7007.8% | -80.5% | — |
| 175 | Telix Pharmaceuticals LimitedTLX | $3.7B | — | — | +55.6% | 3.7% | -1.7% | — |
| 176 | iRhythm Technologies IncIRTC | $3.7B | — | 106.9x | +20.1% | -3.0% | -7.5% | — |
| 177 | Regencell Bioscience Holdings LtdRGC | $3.7B | — | — | — | — | -87.7% | — |
| 178 | Organon & CoOGN | $3.7B | 15.0x | 6.80x | -2.3% | — | 20.8% | 0.49% |
| 179 | Envista Holdings CorpNVST | $3.6B | 54.1x | 15.7x | +7.1% | 9.6% | 3.1% | — |
| 180 | National HealthCare CorporationNHC | $3.6B | 29.1x | 24.1x | +4.1% | 9.7% | 12.5% | 1.1% |
| 181 | Heartflow, Inc. Common StockHTFL | $3.5B | — | — | +47.6% | -37.8% | -42.3% | — |
| 182 | Celcuity LLCCELC | $3.5B | — | — | — | — | — | — |
| 183 | Xenon Pharmaceuticals IncXENE | $3.4B | — | — | — | — | -32.9% | — |
| 184 | Relay Therapeutics IncRLAY | $3.4B | — | — | -48.3% | -2999.4% | -32.1% | — |
| 185 | Arcutis Biotherapeutics IncARQT | $3.3B | — | — | +59.3% | 7.4% | 12.9% | — |
| 186 | ACADIA Pharmaceuticals IncACAD | $3.3B | 8.64x | 31.1x | +16.4% | 7.6% | 29.1% | — |
| 187 | Ideaya Biosciences IncIDYA | $3.3B | — | — | — | -92.7% | -14.6% | — |
| 188 | Legend Biotech CorpLEGN | $3.2B | — | — | +421.9% | — | -29.6% | — |
| 189 | CareDx IncCDNA | $3.2B | — | 89.9x | +52.2% | 23.6% | 26.1% | — |
| 190 | Viking Therapeutics IncVKTX | $3.2B | — | — | — | — | -131.0% | — |
| 191 | Aveanna Healthcare Holdings IncAVAH | $3.0B | 11.5x | 26.5x | +13.7% | 10.5% | 95.6% | — |
| 192 | AtriCure IncATRC | $3.0B | — | 61.9x | +12.8% | 2.3% | 2.0% | — |
| 193 | Tarsus Pharmaceuticals IncTARS | $3.0B | — | — | +69.4% | -8.0% | -13.4% | — |
| 194 | TransMedics Group IncTMDX | $3.0B | 19.7x | 22.2x | +20.7% | 12.2% | 29.3% | — |
| 195 | Arcus Biosciences IncRCUS | $2.9B | — | — | -74.4% | -415.4% | -99.1% | — |
| 196 | Precigen IncPGEN | $2.8B | — | — | +6322.7% | — | -361.9% | — |
| 197 | Amylyx Pharmaceuticals IncAMLX | $2.8B | — | — | — | — | -63.6% | — |
| 198 | Warby Parker IncWRBY | $2.7B | 2184.6x | 61.3x | +9.8% | 0.17% | 2.0% | — |
| 199 | Privia Health Group IncPRVA | $2.7B | 123.8x | 16.3x | +21.4% | 1.9% | 3.6% | — |
| 200 | Tango Therapeutics IncTNGX | $2.6B | — | — | -100.0% | -253.4% | -12.1% | — |
Medians use companies with a value for that measure; P/E only counts companies with positive earnings. Every company links to its page with the reverse DCF, insider buying and 13F holders.
Healthcare industries
Drug Manufacturers - General17 companies · $4.16TBiotechnology200 companies · $1.07TDiagnostics & Research28 companies · $881.3BMedical Devices43 companies · $759.1BHealthcare Plans10 companies · $682.9BMedical Instruments & Supplies25 companies · $417.4BDrug Manufacturers - Specialty & Generic40 companies · $326.3BMedical Distribution5 companies · $249.4BMedical Care Facilities29 companies · $228.5BHealth Information Services17 companies · $129.4B
Other sectors
Questions
What are the largest Healthcare stocks?
By market value: Eli Lilly and (LLY), Johnson & Johnson (JNJ), AbbVie (ABBV), Merck & Company (MRK), UnitedHealth Group (UNH).
What is the average P/E ratio of Healthcare stocks?
The median Healthcare company on Investingly trades at 28.0 times trailing earnings (companies with positive earnings only).
How many Healthcare stocks pay a dividend?
65 of 414, with a median yield of 1.3%.
Prices and ratios as of Oct 11, 2026. Statements from SEC filings. Information only, not investment advice.